Open access
86
Views
15
CrossRef citations to date
0
Altmetric
Original Research
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)
Jose M Marin1 University Hospital Miguel Servet, IISAragón, CIBERES, Zaragoza, Spain
, Kai M Beeh2 Insaf Respiratory Research Institute, Wiesbaden, Germany
, Andreas Clemens3 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
, Walter Castellani4 Hospital Piero Palagi, Fiorenze, Italy
, Lennart Schaper5 Research Institute and Practice, Berlin-Brandenburg, Germany
, Dinesh Saralaya6 Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
, Anthony Gunstone7 Staploe Medical Center, Soham, Cambridge, UK
, Ricard Casamor8 Novartis Farmaceutica SA, Barcelona, Spain
, Konstantinos Kostikas3 Novartis Pharma AG, Basel, Switzerland
& Maryam Aalamian-Mattheis3 Novartis Pharma AG, Basel, Switzerland
show all
Pages 1425-1434
|
Published online: 28 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.